[ Price : $8.95]
FDA warns Indias Kim Chemicals about CGMP and other violations in its manufacturing of OTC products.[ Price : $8.95]
An FDA safety update says that interim study results from a pivotal clinical trial continue to show an increased rate of major adv...[ Price : $8.95]
FDA warns Accelerated Analytical Laboratories about CGMP violations at its drug manufacturing facility.[ Price : $8.95]
FDA says it will recognize drug manufacturing inspections from eight European countries, avoiding duplication of inspections and r...[ Price : $8.95]
As a condition of approval, FDA is requiring that AstraZeneca conduct additional studies to verify and describe anticipated clinic...[ Price : $8.95]
CDRH associate director Suzanne Schwartz says the agency works with medical device manufacturers to address cybersecurity issues.[ Price : $8.95]
Attorney Serra Schlanger says New Jersey is considering a proposal to restrict drug company payments and gifts to healthcare profe...[ Price : $8.95]
FDA clears an Abbott 510(k) for its Alinity ci-series instruments for clinical chemistry and immunoassay diagnostics.